The EHA / Moving Forward team, together with the Federación Española de Personas Afectadas por la Enfermedad de Huntington (FEPAEH) and in collaboration with PTC Therapeutics, organized this webinar to inform the Spanish-speaking community about the phase 2 clinical trial PIVOT-HD and to share the details about the participation of four Spanish sites in this study.
Dr. Esther Cubo, Principal Investigator at the Hospital Universitario de Burgos, Dr. Jose Luis López-Sendón Moreno, Principal Investigator at the Hospital Ramón y Cajal de Madrid, Dr. Tamara Fernández, Principal Investigator at the Hospital Universitario De Cruces en Barakaldo (Bilbao), and Dr. Jaime Kulisevsky, Principal Investigator at the Hospital de la Santa Creu i Sant Pau de Barcelona, participated in the webinar.